Ads

You May Also Like

ScarX Therapeutics closes $2 million Series A financing

TORONTO, Feb. 16, 2016 (GLOBE NEWSWIRE) -- ScarX Therapeutics, a Canadian biotechnology company commercializing ...

Dendritic Cell Vaccine Inhibits Tumor Progression in Preclinical Liver Cancer Model

NEW YORK, Feb. 25, 2016 (GLOBE NEWSWIRE) -- Saronic Biotechnology, Inc. today announces publication ...